Schedule 13G ownership disclosure
CALADRIUS BIOSCIENCES ORD
Security class unavailable · CUSIP: 128058203
Event date: 2021-02-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 949,609
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-010722
- Form type
- SC 13G
- Filer
- LISATA THERAPEUTICS, INC.
- CIK
- CIK 320017
- Filed
- Feb 22, 2021
- Reporting period
- Feb 12, 2021
- Description
- Schedule 13G beneficial ownership